BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 16496339)

  • 21. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.
    Godkin A; Jeanguet N; Thursz M; Openshaw P; Thomas H
    Eur J Immunol; 2001 May; 31(5):1438-46. PubMed ID: 11465100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Protective role of HLA-B27 in HIV and hepatitis C virus infection].
    Neumann-Haefelin C
    Dtsch Med Wochenschr; 2011 Feb; 136(7):320-4. PubMed ID: 21302207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
    Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
    J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopes.
    Ziegler S; Ruhl M; Tenckhoff H; Wiese M; Heinemann FM; Horn PA; Spengler U; Neumann-Haefelin C; Nattermann J; Timm J;
    J Hepatol; 2013 Jan; 58(1):24-30. PubMed ID: 22925811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.
    Urbani S; Amadei B; Fisicaro P; Tola D; Orlandini A; Sacchelli L; Mori C; Missale G; Ferrari C
    Hepatology; 2006 Jul; 44(1):126-39. PubMed ID: 16799989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus mutation affects proteasomal epitope processing.
    Seifert U; Liermann H; Racanelli V; Halenius A; Wiese M; Wedemeyer H; Ruppert T; Rispeter K; Henklein P; Sijts A; Hengel H; Kloetzel PM; Rehermann B
    J Clin Invest; 2004 Jul; 114(2):250-9. PubMed ID: 15254592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Success and failure of virus-specific T cell responses in hepatitis C virus infection.
    Neumann-Haefelin C; Thimme R
    Dig Dis; 2011; 29(4):416-22. PubMed ID: 21894013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance.
    Folgori A; Spada E; Pezzanera M; Ruggeri L; Mele A; Garbuglia AR; Perrone MP; Del Porto P; Piccolella E; Cortese R; Nicosia A; Vitelli A;
    Gut; 2006 Jul; 55(7):1012-9. PubMed ID: 16484505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope.
    Nitschke K; Barriga A; Schmidt J; Timm J; Viazov S; Kuntzen T; Kim AY; Lauer GM; Allen TM; Gaudieri S; Rauch A; Lange CM; Sarrazin C; Eiermann T; Sidney J; Sette A; Thimme R; López D; Neumann-Haefelin C
    J Hepatol; 2014 Jan; 60(1):22-9. PubMed ID: 23978718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
    Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
    J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis.
    Atagunduz P; Appel H; Kuon W; Wu P; Thiel A; Kloetzel PM; Sieper J
    Arthritis Rheum; 2005 Mar; 52(3):892-901. PubMed ID: 15751060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection.
    Dutoit V; Ciuffreda D; Comte D; Gonvers JJ; Pantaleo G
    Eur J Immunol; 2005 Dec; 35(12):3493-504. PubMed ID: 16304636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterologous T cell immunity in severe hepatitis C virus infection.
    Urbani S; Amadei B; Fisicaro P; Pilli M; Missale G; Bertoletti A; Ferrari C
    J Exp Med; 2005 Mar; 201(5):675-80. PubMed ID: 15753202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
    van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
    J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained.
    Lechner F; Gruener NH; Urbani S; Uggeri J; Santantonio T; Kammer AR; Cerny A; Phillips R; Ferrari C; Pape GR; Klenerman P
    Eur J Immunol; 2000 Sep; 30(9):2479-87. PubMed ID: 11009080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of proliferation and differentiation of CD8+ T cells on the progression in patients co-infected with HIV and HCV].
    Zhang YH; Zhao Y; Ma LN; Shi LX; Jin Y; He ZM; Zhang XD; Chen XY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):331-3. PubMed ID: 20387477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural in silico analysis of cross-genotype-reactivity among naturally occurring HCV NS3-1073-variants in the context of HLA-A*02:01 allele.
    Antunes DA; Rigo MM; Silva JP; Cibulski SP; Sinigaglia M; Chies JA; Vieira GF
    Mol Immunol; 2011 Jul; 48(12-13):1461-7. PubMed ID: 21513985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8 epitope escape and reversion in acute HCV infection.
    Timm J; Lauer GM; Kavanagh DG; Sheridan I; Kim AY; Lucas M; Pillay T; Ouchi K; Reyor LL; Schulze zur Wiesch J; Gandhi RT; Chung RT; Bhardwaj N; Klenerman P; Walker BD; Allen TM
    J Exp Med; 2004 Dec; 200(12):1593-604. PubMed ID: 15611288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
    Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
    Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune tolerance to hepatitis C virus acquired during engraftment of bone marrow transplant.
    Godkin A; Openshaw P; Thomas HC
    J Viral Hepat; 2005 Nov; 12(6):604-8. PubMed ID: 16255761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.